The estimated Net Worth of James Mandell is at least 247 千$ dollars as of 10 September 2018. James Mandell owns over 1,000 units of Bluebird bio Inc stock worth over 580$ and over the last 11 years James sold BLUE stock worth over 246,720$.
James has made over 12 trades of the Bluebird bio Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently James sold 1,000 units of BLUE stock worth 150,770$ on 10 September 2018.
The largest trade James's ever made was exercising 8,000 units of Bluebird bio Inc stock on 31 January 2017 worth over 171,440$. On average, James trades about 2,500 units every 63 days since 2014. As of 10 September 2018 James still owns at least 1,000 units of Bluebird bio Inc stock.
You can see the complete history of James Mandell stock trades at the bottom of the page.
James's mailing address filed with the SEC is C/O BLUEBIRD BIO, INC., 150 SECOND STREET, CAMBRIDGE, MA, 02141.
Over the last 11 years, insiders at Bluebird bio Inc have traded over 130,743,125$ worth of Bluebird bio Inc stock and bought 6,469 units worth 399,874$ . The most active insiders traders include Steven Gillis、John Maraganore、Robert I Tepper. On average, Bluebird bio Inc executives and independent directors trade stock every 8 days with the average trade being worth of 6,033$. The most recent stock trade was executed by Thomas J Klima on 3 June 2024, trading 3,834 units of BLUE stock currently worth 3,719$.
we are leading the gene therapy revolution. our integrated product platforms encompass gene therapy, cancer immunotherapy and gene editing – providing us with the potential to treat, and hopefully cure, a broad range of serious diseases. we have a lot of energy, and it’s not just the abundance of coffee that keeps us going. find out what sparks our excitement and inspires us every day.
Bluebird bio Inc executives and other stock owners filed with the SEC include: